Sanda MG - Search Results

1

Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.

Xie YC, Hwang C, Overwijk W, Zeng Z, Eng MH, Mulé JJ, Imperiale MJ, Restifo NP, Sanda MG. Xie YC, et al. Among authors: sanda mg. J Natl Cancer Inst. 1999 Jan 20;91(2):169-75. doi: 10.1093/jnci/91.2.169. J Natl Cancer Inst. 1999. PMID: 9923859 Free PMC article.

2

In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells.

Sanda MG, Bolton E, Mulé JJ, Rosenberg SA. Sanda MG, et al. J Immunother (1991). 1992 Aug;12(2):132-7. doi: 10.1097/00002371-199208000-00008. J Immunother (1991). 1992. PMID: 1504054

3

Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factor.

Barth RJ Jr, Mulé JJ, Asher AL, Sanda MG, Rosenberg SA. Barth RJ Jr, et al. Among authors: sanda mg. J Immunol Methods. 1991 Jul 5;140(2):269-79. doi: 10.1016/0022-1759(91)90380-x. J Immunol Methods. 1991. PMID: 1906077

4

Molecular characterization of defective antigen processing in human prostate cancer.

Sanda MG, Restifo NP, Walsh JC, Kawakami Y, Nelson WG, Pardoll DM, Simons JW. Sanda MG, et al. J Natl Cancer Inst. 1995 Feb 15;87(4):280-5. doi: 10.1093/jnci/87.4.280. J Natl Cancer Inst. 1995. PMID: 7707419 Free PMC article.

5

Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer.

Cole DJ, Sanda MG, Yang JC, Schwartzentruber DJ, Weber J, Ettinghausen SE, Pockaj BA, Kim HI, Levin RD, Pogrebniak HW, et al. Cole DJ, et al. Among authors: sanda mg. J Natl Cancer Inst. 1994 Jan 5;86(1):39-45. doi: 10.1093/jnci/86.1.39. J Natl Cancer Inst. 1994. PMID: 8271281 Clinical Trial.

6

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: sanda mg. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

7

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

8

Early castration reduces prostatic carcinogenesis in transgenic mice.

Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG. Eng MH, et al. Among authors: sanda mg. Urology. 1999 Dec;54(6):1112-9. doi: 10.1016/s0090-4295(99)00297-6. Urology. 1999. PMID: 10604719

9

Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development.

Charles LG, Xie YC, Restifo NP, Roessler B, Sanda MG. Charles LG, et al. Among authors: sanda mg. World J Urol. 2000 Apr;18(2):136-42. doi: 10.1007/s003450050186. World J Urol. 2000. PMID: 10854149 Free PMC article.

10

Prospects for an SV40 vaccine.

Imperiale MJ, Pass HI, Sanda MG. Imperiale MJ, et al. Among authors: sanda mg. Semin Cancer Biol. 2001 Feb;11(1):81-5. doi: 10.1006/scbi.2000.0349. Semin Cancer Biol. 2001. PMID: 11243902 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters